Pictet Asset Management Sa Neoleukin Therapeutics, Inc. Transaction History

Pictet Asset Management Sa

  • $83.4 Billion
  • Q2 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$0.92 - $2.25 $1.65 Million - $4.03 Million
-1,792,764 Reduced 69.64%
781,551 $805,000
Q1 2022

May 13, 2022
BUY
$1.72 - $5.23 $44 - $135
26 Added 0.0%
2,574,315 $4.84 Million
Q4 2021

Feb 10, 2022
SELL
$4.65 - $7.75 $419,439 - $699,065
-90,202 Reduced 3.39%
2,574,289 $12.4 Million
Q3 2021

Nov 12, 2021
BUY
$6.05 - $9.66 $16.1 Million - $25.7 Million
2,664,491 New
2,664,491 $19.3 Million

Others Institutions Holding NLTX

# of Institutions
1
Shares Held
199K
Call Options Held
0
Put Options Held
0
View Full List

About Neoleukin Therapeutics, Inc.

NLTX Quotes by TradingView
  • Ticker NLTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,579,900
  • Description
  • Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...
More about NLTX
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email